Cardiol Therapeutics Ownership | Who Owns Cardiol Therapeutics?

Cardiol Therapeutics Ownership Summary

Cardiol Therapeutics is owned by 6.44% institutional investors, 2.43% insiders, and 91.13% retail investors. Mmcap inc. spc is the largest institutional shareholder, holding 15.31% of CRDL shares. Global X Marijuana Life Sciences ETF is the top mutual fund, with 0.79% of its assets in Cardiol Therapeutics shares.

CRDL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cardiol Therapeutics	6.44%	2.43%	91.13%
Sector	Healthcare Stocks	35.34%	11.88%	52.77%
Industry	Specialty & Generic Drug Manufacturers Stocks	20.67%	13.90%	65.43%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Mmcap inc. spc	15.35M	15.31%	$20.73M
Tejara capital	5.13M	5.12%	$6.93M
Ikarian capital	2.73M	2.72%	$3.68M
Citadel advisors	819.90K	0.82%	$1.11M
Boothbay fund management	794.88K	0.79%	$1.07M
Two sigma investments, lp	534.21K	0.53%	$721.18K
Brokers financial services, llc.	465.02K	0.46%	$629.83K
Goldman sachs group	332.40K	0.33%	$448.74K
Morgan stanley	250.42K	0.25%	$338.07K
Renaissance	229.81K	0.23%	$310.24K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tejara capital	5.13M	2.28%	$6.93M
Mmcap inc. spc	15.35M	1.79%	$20.73M
Ikarian capital	2.73M	0.30%	$3.68M
Pvg asset management	97.17K	0.20%	$92.68K
Sheets smith investment management	142.10K	0.10%	$152.04K
Knoll capital management	100.00K	0.07%	$135.00K
Security national bank of sioux city iowa /ia/	33.00K	0.03%	$44.55K
Brokers financial services, llc.	465.02K	0.02%	$629.83K
Scientech research	15.18K	0.02%	$20.49K
Boothbay fund management	794.88K	0.01%	$1.07M

Top Buyers

Holder	Shares	% Assets	Change
Mmcap inc. spc	15.35M	1.79%	15.14M
Ikarian capital	2.73M	0.30%	2.73M
Citadel advisors	819.90K	0.00%	819.90K
Boothbay fund management	794.88K	0.01%	794.88K
Renaissance	229.81K	0.00%	229.81K

Top Sellers

Holder	Shares	% Assets	Change
Advisorshares investments	-	-	-597.98K
Lion street advisors	-	-	-340.02K
Cambridge investment research advisors	-	-	-206.26K
Foundations investment advisors	-	-	-161.95K
Marshall wace, llp	-	-	-151.52K

New Positions

Holder	Shares	% Assets	Change	Value
Ikarian capital	2.73M	0.30%	2.73M	$3.68M
Boothbay fund management	794.88K	0.01%	794.88K	$1.07M
Renaissance	229.81K	0.00%	229.81K	$310.24K
Sheets smith investment management	142.10K	0.10%	142.10K	$152.04K
Jpmorgan chase	48.08K	-	48.08K	$58.65K

Sold Out

Holder	Change
Toronto dominion bank	-1.00
Wells fargo & company/mn	-25.00
Mai capital management	-25.00
Optima capital	-28.00
Stone house investment management	-50.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	26	-40.91%	6,459,344	-29.03%	6	5.58%	11	-45.00%	4	-69.23%
Dec 31, 2025	35	-28.57%	8,453,824	15.86%	9	12.80%	17	-19.05%	9	-30.77%
Sep 30, 2025	47	27.03%	7,154,200	12.91%	8	14.71%	21	40.00%	12	9.09%
Jun 30, 2025	39	-2.50%	6,210,163	-19.45%	7	6.17%	18	-5.26%	10	-
Mar 31, 2025	38	-11.63%	7,252,660	-3.08%	10	8.77%	18	-21.74%	9	50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Global X Marijuana Life Sciences ETF	882.00K	0.79%	-
AdvisorShares Pure Cannabis ETF	557.39K	0.67%	-220.00K
Velten Strategie Welt C	72.00K	0.09%	72.00K
PPF Helix Biotechnology I USD	55.00K	0.07%	55.00K
PPF Global Biotech I USD	55.00K	0.07%	55.00K
iShares S&P/TSX Small Cap ETF	48.85K	0.06%	-
Fidelity Nasdaq Composite Index	52.44K	0.05%	-
Ninepoint Alternative Health A	12.50K	0.01%	-
Ninepoint Cannabis & Alt Health S A	12.50K	0.01%	-
I.B.I TRK Solactive N American Cannabis	4.93K	0.01%	-122.00

CRDL Ownership FAQ

Who Owns Cardiol Therapeutics?

Cardiol Therapeutics shareholders are primarily institutional investors at 6.44%, followed by 2.43% insiders and 91.13% retail investors. The average institutional ownership in Cardiol Therapeutics's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which Cardiol Therapeutics falls below.

Who owns the most shares of Cardiol Therapeutics?

Cardiol Therapeutics’s largest shareholders are Mmcap inc. spc (15.35M shares, 15.31%), Tejara capital (5.13M shares, 5.12%), and Ikarian capital (2.72M shares, 2.72%). Together, they hold 23.15% of Cardiol Therapeutics’s total shares outstanding.

Does Blackrock own Cardiol Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cardiol Therapeutics.

Who is Cardiol Therapeutics’s biggest shareholder by percentage of total assets invested?

Tejara capital is Cardiol Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.28% of its assets in 5.13M Cardiol Therapeutics shares, valued at 6.93M$.

Who is the top mutual fund holder of Cardiol Therapeutics shares?

Global X Marijuana Life Sciences ETF is the top mutual fund holder of Cardiol Therapeutics shares, with 0.79% of its total shares outstanding invested in 882K Cardiol Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools